C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2002
12/03/2002	US6489118 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies
12/03/2002	US6489117 Enzymatic polypeptide for use in diagnosis of skin disorders
12/03/2002	US6489100 Increasing 3' deoxy-d-arabino-heptulosonate (dahb) production relative to wild type host cells, comprising the steps of: transforming a genetic agent into a microorganism to overexpress pps to convert pyruvate to phosphoenolpyruvate
12/03/2002	US6489099 Detection of DNA damaging agents
12/03/2002	US6488935 Dna coding for a peptide of a papilloma virus major capsid protein and a papilloma virus genome, respectively
12/03/2002	CA2284077C Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
12/03/2002	CA2222758C Cereal product containing probiotics
12/03/2002	CA2060544C Recombinant antibodies specific for a growth factor receptor
12/03/2002	CA2050910C Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
11/2002
11/30/2002	CA2384352A1 Novel polynucleotides from streptomyces avermitilis
11/29/2002	CA2387879A1 Culture, formulation, and delivery techniques of valdensinia heterodoxa and its use as a biological control agent of salal (gaultheria shalllon)
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095058A2 Emission ratiometric indicators of phosphorylation
11/28/2002	WO2002095056A2 A novel g protein-coupled receptor, gave1
11/28/2002	WO2002095055A2 Compositions and methods for use in isolation of nucleic acid molecules
11/28/2002	WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules
11/28/2002	WO2002095039A1 Protease deficient caulobacter host cells
11/28/2002	WO2002095036A2 A novel intein and uses thereof
11/28/2002	WO2002095029A2 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria
11/28/2002	WO2002095025A1 Novel smg-1
11/28/2002	WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	WO2002095014A2 Polypeptides having cellobiase activity and polynucleotides encoding same
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095006A2 Muscle-specific expression vectors
11/28/2002	WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them
11/28/2002	WO2002095002A2 N4 virion single-stranded dna dependent rna polymerase
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094980A2 Phytocystatin
11/28/2002	WO2002094880A1 Anti-trail-r antibodies
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094874A2 Internalisation of virus into cells
11/28/2002	WO2002094870A2 Proteins and nucleic acids encoding same
11/28/2002	WO2002094867A2 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/28/2002	WO2002094866A1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine
11/28/2002	WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094851A2 Peptide vaccines against group a streptococci
11/28/2002	WO2002094780A2 Kinases and phosphatases
11/28/2002	WO2002094775A2 Recombinant simian gpr3 receptor
11/28/2002	WO2002094181A2 Gram-positive fatty acid degrader
11/28/2002	WO2002094029A1 Method of inhibiting fungal growth
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002081631A3 Uncoupled productive and catabolic host cell pathways
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002064086A3 Method for the separation of adsorbents from microbiological growth media
11/28/2002	WO2002061038A9 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
11/28/2002	WO2002040538A3 Regulation of human nmda receptor
11/28/2002	WO2002034906A3 Method for exposing peptides and polypeptides on the cell surface of bacteria
11/28/2002	WO2002031174A3 Process for preparing optically active 4-hydroxy-2-pyrrolidinone and n-substituted 4-hydroxy-2-pyrrolidinones by enzymatic hydroxylation
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002	WO2001081623A3 Neuronally expressed protein having apoptotic activity, and use thereof
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001073108A3 A bacterial two-hybrid system for protein interaction screening
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178458 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177715 Quinone-indicator antibiotics; controlling gene expression
11/28/2002	US20020177700 New ras-like protein
11/28/2002	US20020177690 Novel antimicrobial polypeptides and methods of use
11/28/2002	US20020177569 Tuberculosis vaccine
11/28/2002	US20020177565 Toso proteins and related molecules which have an inhibitory effect on TNF mediated apoptosis
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020177549 Which regulate cellular guidance and physiology, and related nucleic acids.
11/28/2002	US20020177218 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020177210 Polypeptide for use as tools in food processing and genetic engineering
11/28/2002	US20020177209 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/28/2002	US20020177203 Alpha2 subunit of prolyl 4-hydroxylase
11/28/2002	US20020177202 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acids
11/28/2002	US20020177201 Channel protein for use in the treatment of nervous system, brain and epileptic
11/28/2002	US20020177199 Generating fuel from preferential particles within biomass; obtain biomass mixture, adjust hydrogen ion concentration, incubate with metal oxide, remove bound complex, elute, incubate with microorganism, recover fuel
11/28/2002	US20020177198 Generation of ascorbic acid intermediates; cells, incubate with carbon source, incubate with enzymes, recover ascorbic acid intermediates
11/28/2002	US20020177197 Generation of ascorbic acid intermediates; cells, incubate with carbon source, incubate with enzymes, recover ascorbic acid intermediates
11/28/2002	US20020177194 Polypeptide for use in the treatment of immunological, allergies and autoimmune diseases
11/28/2002	US20020177191 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
11/28/2002	US20020177190 Nucleotide sequences coding polypeptide for use in the treatment of hypertension and vision defects
11/28/2002	US20020177189 Novel fluorescent proteins
11/28/2002	US20020177187 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/28/2002	US20020177155 Normalized nucleic acid libraries and methods of production thereof
11/28/2002	US20020177137 Detecting preferential nucleotide sequences in pool of sequences; obtain nucleotide sequences, deposit on substrate, incubate with probe, detect signal, which indicates, presencec of preferential sequences
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	US20020177124 Nucleotide sequences coding polypeptide for use in the detection, prevention and diagnosis viral diseases
11/28/2002	US20020177116 Compositions and methods for the preservation of living tissues
11/28/2002	US20020176884 Process for the fermentative preparation of D-pantothenic acid and/or salts thereof
11/28/2002	US20020176873 A nucleic acid conisting of a deletion marker, and hybridizes to a Mycobactirium tuberculosis complex genome when the deletion is present, but not in an deleted genome
11/28/2002	US20020176864 Two-domain MHC polypeptides include MHC( major histocompatibility complex) class II-based molecules that covalently linked beta 1 and alpha 1 domains, and MHC class I-based molecules that covalently linked alpha-1 and alpha-2
11/28/2002	US20020176852 Mitogenic oxygenase regulators
11/28/2002	DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins
11/28/2002	DE10123041A1 New single-chain human antibody fragment, useful for treating or diagnosing hepatitis C virus infection, has affinity for an essential viral protein
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2450677A1 A novel intein and uses thereof
11/28/2002	CA2448505A1 Compositions and methods for use in isolation of nucleic acid molecules
11/28/2002	CA2448186A1 Novel smg-1
11/28/2002	CA2448120A1 Muscle-specific expression vectors

1 ... 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 ... 1489